GO:0015810 aspartate transmembrane transport: Mitochondrial Antiport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015810 describes the movement of aspartate across a lipid bilayer, a process essential for mitochondrial redox shuttling and synaptic signaling.
• The mitochondrial aspartate/glutamate antiporters of the SLC25 family are the best-characterized transporters mediating this process.
• Bacterial aspartate:alanine transporters such as AspT provide mechanistic insight into substrate recognition and transport coupling.
• Aspartate transport is critical for the malate-aspartate shuttle, which transfers reducing equivalents into mitochondria for oxidative phosphorylation.
• Dysregulation of aspartate transport is linked to citrin deficiency, a metabolic disorder caused by mutations in SLC25A13.
• Research on aspartate transmembrane transport uses synaptosome assays, proteoliposome reconstitution, and CRISPR-engineered cell models.
Description
Aspartate transmembrane transport (GO:0015810) is the biological process by which the amino acid aspartate is moved across a lipid bilayer from one side of a membrane to the other. This process is fundamental to cellular metabolism, neurotransmission, and energy homeostasis. In mitochondria, aspartate transport is coupled to glutamate transport via antiporters of the mitochondrial carrier family, enabling the malate-aspartate shuttle that transfers reducing equivalents from the cytosol to the electron transport chain. In the nervous system, aspartate transport in synaptosomes regulates neurotransmitter pools and excitatory signaling. In bacteria, dedicated transporters such as AspT mediate aspartate uptake and exchange, providing model systems for understanding substrate specificity and transport mechanisms. Researchers study GO:0015810 to dissect metabolic reprogramming in cancer, inborn errors of metabolism such as citrin deficiency, and the molecular basis of membrane transport.
aspartate transmembrane transport At A Glance
| GO ID | GO:0015810 |
|---|---|
| GO term | aspartate transmembrane transport |
| Ontology | biological_process |
| Synonym | aspartate transport; mitochondrial aspartate/glutamate transport |
| Major function | Movement of aspartate across membranes, often coupled to glutamate or proton gradients |
| Key transporters | SLC25A12, SLC25A13, SLC1A1, SLC1A2, SLC1A3, AspT |
| Cellular locations | Mitochondrial inner membrane, plasma membrane, synaptic vesicles |
| Associated diseases | Citrin deficiency, hyperammonemia, neurodegenerative disorders |
| Research methods | Synaptosome uptake assays, proteoliposome reconstitution, CRISPR knockout models |
What Is GO:0015810?
According to the Gene Ontology, GO:0015810 (aspartate transmembrane transport) is defined as the process in which aspartate is transported across a lipid bilayer, from one side of a membrane to the other. This includes transport mediated by dedicated transporters, antiporters, and channels, and encompasses both plasma membrane and organellar membranes. Synonyms include aspartate transport and mitochondrial aspartate/glutamate transport.
Why Is aspartate transmembrane transport Important in Cell Biology?
Aspartate transmembrane transport is central to the malate-aspartate shuttle, which is the primary mechanism for transferring reducing equivalents from cytosolic NADH into mitochondria for oxidative phosphorylation. This process is essential for maintaining cellular energy balance, nitrogen metabolism, and neurotransmitter homeostasis. Defects in aspartate transport are linked to citrin deficiency, a disease characterized by hyperammonemia and liver dysfunction. In the brain, aspartate transport in synaptosomes modulates excitatory signaling and protects against excitotoxicity. Understanding GO:0015810 therefore has broad implications for metabolic disorders, neurobiology, and cancer metabolism.
• Enables the malate-aspartate shuttle for mitochondrial NADH oxidation.
• Regulates cytosolic and mitochondrial aspartate pools for urea cycle and nucleotide synthesis.
• Modulates synaptic aspartate and glutamate levels, influencing excitatory neurotransmission.
• Provides a model for studying antiport mechanisms in the mitochondrial carrier family.
• Bacterial AspT serves as a paradigm for substrate recognition in secondary transporters.
• Dysfunction of SLC25A13 causes citrin deficiency, an inborn error of metabolism.
• Aspartate transport is implicated in cancer metabolic reprogramming and redox balance.
• Transport assays in synaptosomes reveal regulation by ions and membrane potential.
• Targeting aspartate transporters may offer therapeutic strategies for hyperammonemia.
• CRISPR screens can identify novel regulators of aspartate transport and metabolism.
What Happens During aspartate transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first grabs aspartate from one side of the membrane.
Transporters of the mitochondrial carrier family, such as SLC25A12 and SLC25A13, recognize aspartate via specific residues in their transmembrane domains. In the bacterial aspartate:alanine transporter AspT, arginine 76 in transmembrane domain 3 is critical for substrate binding and transport. This step ensures selectivity for aspartate over other amino acids.
Conformational change and translocation
In simple terms: The transporter changes shape to move aspartate across the membrane.
Upon binding, the transporter undergoes a conformational shift that exposes the substrate to the opposite side of the membrane. For mitochondrial antiporters, this process is coupled to the counter-transport of glutamate or protons. The alternating access mechanism is a hallmark of the mitochondrial carrier family.
Coupling to glutamate or proton gradients
In simple terms: Aspartate transport is often powered by exchanging it for another molecule.
The mitochondrial aspartate/glutamate antiporters exchange aspartate for glutamate, driven by the electrochemical gradient. This exchange is essential for the malate-aspartate shuttle. In bacteria, AspT can couple aspartate transport to alanine efflux, demonstrating diverse coupling modes.
Release and resetting
In simple terms: Aspartate is released on the other side, and the transporter resets.
After translocation, aspartate is released into the mitochondrial matrix or cytoplasm, and the transporter returns to its initial conformation. This cycle is regulated by substrate availability and membrane potential. In synaptosomes, aspartate transport is influenced by sodium and calcium ions.
Key Genes Involved in GO:0015810 aspartate transmembrane transport
The following genes encode transporters, enzymes, and regulatory proteins directly involved in aspartate transmembrane transport (GO:0015810) or its metabolic context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A12 | Mitochondrial aspartate/glutamate antiporter (aralar) | Malate-aspartate shuttle, energy metabolism |
| SLC25A13 | Mitochondrial aspartate/glutamate antiporter (citrin) | Citrin deficiency, hyperammonemia |
| SLC1A1 | Neuronal glutamate/aspartate transporter | Synaptic aspartate uptake, excitotoxicity |
| SLC1A2 | Glial glutamate/aspartate transporter | Neurotransmitter clearance |
| SLC1A3 | Glial glutamate/aspartate transporter | Synaptic homeostasis |
| AspT | Bacterial aspartate:alanine antiporter | Model for substrate recognition |
| GOT1 | Cytosolic aspartate aminotransferase | Malate-aspartate shuttle |
| GOT2 | Mitochondrial aspartate aminotransferase | Malate-aspartate shuttle |
| MDH1 | Cytosolic malate dehydrogenase | Shuttle component |
| MDH2 | Mitochondrial malate dehydrogenase | Shuttle component |
| ASS1 | Argininosuccinate synthase | Uses aspartate for urea cycle |
| ASL | Argininosuccinate lyase | Urea cycle, aspartate recycling |
| CAD | Carbamoyl-phosphate synthetase 2 | Pyrimidine synthesis, aspartate utilization |
| SLC25A22 | Mitochondrial glutamate transporter | Glutamate/aspartate exchange |
| SPP/SPPL | Intramembrane proteases | Regulate transporter turnover |
| ABCD4 | Cobalamin transporter | Transmembrane helix 6 in transport |
How Is aspartate transmembrane transport Regulated?
Aspartate transmembrane transport is regulated at multiple levels. The expression of mitochondrial carriers SLC25A12 and SLC25A13 is controlled by metabolic demands and transcription factors such as PGC-1α. In neurons, aspartate transport in synaptosomes is modulated by membrane potential, sodium, and calcium ions. Intramembrane proteases of the SPP/SPPL family can cleave and regulate membrane transporters, influencing their stability and function. Additionally, the malate-aspartate shuttle activity is feedback-regulated by the redox state and substrate availability.
aspartate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A13 | Citrin deficiency, hyperammonemia | Knockout hepatocyte cell line, patient iPSCs |
| SLC25A12 | Neurodevelopmental disorders, cancer metabolism | Knockout neuroblastoma cells, xenografts |
| SLC1A1 | Epilepsy, excitotoxicity | Knockout neurons, synaptosome assays |
| SLC1A2 | ALS, glutamate excitotoxicity | Knockout astrocytes, co-culture models |
| AspT | Bacterial transport mechanism | Point mutations in E. coli, proteoliposomes |
Citrin deficiency
Mutations in SLC25A13, which encodes the mitochondrial aspartate/glutamate antiporter citrin, cause citrin deficiency, an autosomal recessive disorder characterized by hyperammonemia, liver dysfunction, and neuropsychiatric symptoms. The disease highlights the critical role of aspartate transport in the urea cycle and energy metabolism.
Neurodegeneration and excitotoxicity
Aspartate is an excitatory amino acid, and its transport in synaptosomes is tightly regulated to prevent excitotoxicity. Dysregulation of aspartate transporters such as SLC1A1, SLC1A2, and SLC1A3 has been implicated in neurodegenerative conditions including amyotrophic lateral sclerosis and epilepsy.
Cancer metabolism
Aspartate is essential for nucleotide synthesis and redox balance in proliferating cancer cells. Mitochondrial aspartate transport via SLC25A12 and SLC25A13 supports the malate-aspartate shuttle, which is often upregulated in cancer. Targeting these transporters is a potential therapeutic strategy.
From aspartate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A13 impair aspartate transport? | SLC25A13 knockout HEK293 or HepG2 cells |
| How does a point mutation in AspT affect substrate specificity? | AspT R76A knock-in in E. coli |
| Can we visualize aspartate transporter localization? | SLC25A12-GFP knock-in cell line |
| Does overexpression of SLC25A12 enhance shuttle activity? | SLC25A12 overexpression in cancer cells |
| What genes regulate aspartate transport? | CRISPR library screening in metabolic stress |
| Does citrin deficiency alter urea cycle flux? | Patient iPSC-derived hepatocytes |
How to Study the aspartate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Synaptosome aspartate transport |
| Proteoliposome reconstitution | Substrate specificity and antiport | Bacterial AspT mechanism |
| CRISPR knockout + metabolomics | Metabolic flux and shuttle activity | SLC25A13 function in liver cells |
| Seahorse extracellular flux | Mitochondrial respiration | Malate-aspartate shuttle dependence |
| Western blot | Transporter protein levels | Expression changes in disease models |
| Immunofluorescence | Subcellular localization | Mitochondrial vs plasma membrane |
| RNA-seq | Transcriptional regulation | Identifying co-regulated genes |
| CRISPR library screening | Genes required for transport | Novel regulators of aspartate metabolism |
Synaptosome uptake assays
Synaptosomes isolated from rat brain are used to measure radiolabeled aspartate uptake, revealing transport kinetics and regulation by ions. This method is classic for studying neuronal aspartate transport.
Proteoliposome reconstitution
Purified transporters such as AspT can be reconstituted into proteoliposomes to study substrate specificity and antiport activity in a defined system. This allows precise measurement of transport rates.
CRISPR knockout and metabolic profiling
CRISPR-Cas9 knockout of SLC25A12 or SLC25A13 in cell lines followed by metabolomics and Seahorse analysis reveals their role in the malate-aspartate shuttle and energy metabolism.
Live-cell imaging with fluorescent reporters
Genetically encoded aspartate sensors or tagged transporters can be used to monitor real-time transport dynamics in living cells. This approach complements biochemical assays.
How CRISPR Can Be Used to Study GO:0015810 aspartate transmembrane transport
Knockout
CRISPR knockout of SLC25A13 or SLC25A12 in cell lines abolishes mitochondrial aspartate/glutamate exchange, leading to impaired malate-aspartate shuttle and altered metabolism. These models are valuable for studying citrin deficiency and cancer metabolism.
Point Mutation
Introducing point mutations such as R76A in the bacterial AspT gene allows dissection of substrate binding residues. In human SLC25A13, patient-derived mutations can be modeled to understand loss of function.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous SLC25A12 or SLC25A13 loci enables real-time imaging of transporter localization and dynamics without overexpression artifacts.
Overexpression
Overexpression of SLC25A12 or SLC25A13 in cancer cell lines enhances the malate-aspartate shuttle and supports proliferation under metabolic stress. This approach helps identify dependencies on aspartate transport.
How EDITGENE Supports aspartate transmembrane transport Research
Researchers studying aspartate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling functional validation of transporters, enzymes, and regulatory proteins.
Contact EDITGENE today to design your custom CRISPR model for aspartate transmembrane transport research.
Frequently Asked Questions About aspartate transmembrane transport
What is aspartate transmembrane transport?
Aspartate transmembrane transport (GO:0015810) is the process of moving aspartate across a lipid bilayer, often coupled to glutamate or proton gradients.
What genes are involved in aspartate transmembrane transport?
Key genes include SLC25A12, SLC25A13, SLC1A1, SLC1A2, SLC1A3, and the bacterial AspT.
What is the function of SLC25A13 in aspartate transport?
SLC25A13 encodes citrin, a mitochondrial aspartate/glutamate antiporter essential for the malate-aspartate shuttle and urea cycle.
How is aspartate transport studied in the lab?
Common methods include synaptosome uptake assays, proteoliposome reconstitution, and CRISPR knockout models.
What diseases are linked to aspartate transport defects?
Citrin deficiency, hyperammonemia, and neurodegenerative disorders are associated with impaired aspartate transport.
What is the malate-aspartate shuttle?
It is a metabolic pathway that transfers reducing equivalents from cytosolic NADH into mitochondria via aspartate and glutamate antiporters.
Can CRISPR be used to study aspartate transporters?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect transporter function.
What is the role of AspT in aspartate transport?
AspT is a bacterial aspartate:alanine antiporter that serves as a model for understanding substrate recognition and transport.
How is aspartate transport regulated in neurons?
In synaptosomes, aspartate transport is regulated by membrane potential, sodium, and calcium ions.
What are the synonyms for GO:0015810?
Synonyms include aspartate transport and mitochondrial aspartate/glutamate transport.
Conclusion
Aspartate transmembrane transport (GO:0015810) is a fundamental biological process that underpins mitochondrial energy metabolism, neurotransmitter regulation, and nitrogen homeostasis. The mitochondrial aspartate/glutamate antiporters SLC25A12 and SLC25A13 are central to the malate-aspartate shuttle, and their dysfunction causes citrin deficiency and contributes to cancer and neurodegeneration. Bacterial models such as AspT provide mechanistic insights into substrate recognition. Continued research using CRISPR-engineered cell models and advanced metabolic assays will further illuminate the regulation and therapeutic potential of aspartate transport.
References
- 1. Imai M et al.. 2024. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.. J Inherit Metab Dis 47(2):366-373 PMID: 38069516
- 2. Walker JE. 2025. My path to citrin deficiency.. J Inherit Metab Dis 48(1):e12818 PMID: 39581577
- 3. Mentrup T et al.. 2020. Physiological functions of SPP/SPPL intramembrane proteases.. Cell Mol Life Sci 77(15):2959-2979 PMID: 32052089
- 4. Suzuki S et al.. 2016. R76 in transmembrane domain 3 of the aspartate:alanine transporter AspT is involved in substrate transport.. Biosci Biotechnol Biochem 80(4):744-7 PMID: 26849958
- 5. Monné M et al.. 2014. Antiporters of the mitochondrial carrier family.. Curr Top Membr 73:289-320 PMID: 24745987
- 6. Erecińska M et al.. 1983. Aspartate transport in synaptosomes from rat brain.. J Biol Chem 258(15):9069-77 PMID: 6874678
